 the abstract summarizes the main findings of this research paper. It states that the authors identified the key components of the herbal medicine Yin-Lan-Ciaoji capsules, YLTZC, which are believed to be responsible for treating hypolipidemia, HLP. These components include two specific compounds, naryngin and ferulic acid, which are thought to interact with certain genes and proteins associated with HLP. The authors also conducted experiments to confirm their hypothesis, which demonstrated that these two compounds can reduce levels of inflammation and promote healthy blood vessel growth. This suggests that YLTZC could potentially be used to treat HLP. This article was offered by Guan Lin-Xiao, Zishuang Hu, Kanchao Chiao, and others.